Best Follicular lymphoma doctors in Israel: TOP 21 doctors

Dr. Ram Ron is an Associate Professor and senior specialist in hemato-oncology and bone marrow transplantation at Tel Aviv Sourasky Medical Center.

• Over 24 years of experience of specialized clinical and academic experience
• Associate Professor at Tel Aviv University – trains future specialists
• Focuses on lymphoma, leukemia, and myeloma as a hematologist
• Expert in high-dose chemotherapy and bone marrow transplants for blood cancers
• Published 90+ research articles in leading medical journals

Has performed several hundred stem cell transplants, a key treatment for follicular lymphoma, at Sourasky Medical Center (Ichilov).

• Board-certified in hematology, oncology, and internal medicine
• Authored over 30 scientific articles and a textbook chapter
• Completed a specialized hematology and oncology fellowship in New York
• Extensive academic contributions to the medical field

Dr. Ronit El Hasid is a leading pediatric specialist who has performed over 300 bone marrow and cord blood transplants at Dana Dwek Children's Hospital.

• Head of the Pediatric Oncohematology and Oncology Department
• Specializes in transplants for children with blood cancers and disorders
• Member of the American Society of Hematology
• Holds membership in the Israeli Society for Pediatric Hematooncology
• Trained at the prestigious City of Hope Hospital in Los Angeles

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Dr. Michael Shapira specializes in Bone Marrow Transplantation at Sourasky Medical Center (Ichilov), with extensive training at top institutions.

• Graduated from Hebrew University Medical School
• Specialized in internal medicine at Hadassah Medical Center
• Senior physician in Bone Marrow Transplantation at Hadassah
• Fluent in English and Hebrew for clear communication

Dr. Fredi Aviv has 34 years of experience of experience treating hematological cancers at one of Israel's top hospitals – Sourasky Medical Center (Ichilov).

• Board-certified oncohematologist, specializing in blood and lymphatic system cancers.
• Spent his entire career working at Sourasky Medical Center.
• Deep focus on adult cancer care in a major university hospital setting.

Dr. Levin is the director of the pediatric hematology oncology department at Sourasky Medical Center in Tel Aviv, focusing on blood disorders and childhood cancers.

• Coordinates treatment of bone cancer (sarcoma) in children with the Oncology-orthopedic department
• Specializes in pediatric hematology and oncology, trained at Schneider Children's Medical Center
• Member of the Israel Society of Pediatric Hematology Oncology (ISPHO)
• Studied oncology at Rizzoli Orthopaedic Institute in Bologna – a leading global center

Dr. Kirshner is actively involved in cutting-edge clinical trials, including testing new treatments for resistant cancers at Sourasky Medical Center.

• Double fellowship-trained in hematology and medical oncology
• Over 32 years of experience of experience treating blood cancers
• Participates in phase III clinical trials for advanced therapies
• Specializes in treatment-resistant cases of follicular lymphoma

Multiple award-winning hematologist specializing in chronic lymphocytic leukemia – Dr. Herishanu Yair brings research-backed expertise to patient care at Sourasky Medical Center.

• 24 years of experience of experience in hematology
• Recipient of prestigious grants from the Israeli Science Foundation and Weizmann Institute
• Member of both Israeli and American Hematology Associations
• Trained at top Israeli medical institutions
• Published researcher in hematology

Dr. Ofer Spielberg is a dedicated oncohematologist specializing in blood cancers like follicular lymphoma at Assuta Medical Center.

• Focuses exclusively on the diagnosis and treatment of hematological malignancies
• Part of a leading oncology department in Israel
• Expertise in modern treatment protocols for lymphoma

Specializes in the treatment of lymphomas at Rambam Medical Center.

• Specialist in hematology
• Focused expertise in lymphoma treatments
• Works at a leading medical center

Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants.

• 28 years of experience of experience in pediatric hematology
• Specializes in treating rare blood cancers in children
• Patients and families refer to her as 'the one who transplants life'
• Works at Hadassah Medical Center

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.